The Nasdaq Now: Acadia Pharmaceuticals Soars Over 140% on Drug Trial … – Minyanville.com
 Proactive Investors USA & Canada |
The Nasdaq Now: Acadia Pharmaceuticals Soars Over 140% on Drug Trial …
Minyanville.com MINYANVILLE ORIGINAL As negotiations continue in Washington on a deal to avert the automatic spending cuts and tax increases set to kick in at the start of the new year, US equities stayed largely unchanged in spite of some positive economic reports. Acadia Stock Soars On Positive Results From Antipsychotic Drug Trial – Update Parkinsons Drug Makers Acadia (ACAD) Hits it out of Park +150% – ACRX … |
